Global Pelvic Floor Diagnostic Testing Market: Industry Analysis and Forecast (2021-2027) by Product, End-User, and Region

Global Pelvic Floor Diagnostic Testing Market size was valued at US$ 3.24 Bn in 2020 and the total revenue is expected to grow at 4.3% through 2021 to 2027, reaching nearly US$ 4.35 Bn.

Global Pelvic Floor Diagnostic Testing Market Overview:

The Pelvic Floor is a combination of various muscles that are responsible to support the rectum. To initiate bowel movement pelvic floor muscles contract and relax in sync to regulate bowel movement, bladder function, sexual intercourse in women, and urination. Pelvic floor dysfunction occurs due to high tension on the pelvic floor muscles and this leads to various issues such as pain in the back, pelvic region, genital area, constipation, and painful urination. To treat pelvic floor dysfunction various tests are performed and diagnosis is carried out. Global Pelvic Floor Diagnostic Testing Market To know about the Research Methodology :- Request Free Sample Report The report has covered the market trends from 2015 to forecast the market through 2027. 2020 considered a base year however 2020's numbers are on the real output of the companies in the market. Special attention is given to 2020 and the effect of lockdown on the demand and supply, and also the impact of lockdown for the next two years on the market. Some companies have done good in lockdown also and specific strategic analysis of those companies is done in the report.

Global Pelvic Floor Diagnostic Testing Market Dynamics:

Expansion of the geriatric population globally, urinary incontinence in pregnant women, and awareness & healthcare programs for treatment options are projected to boost the growth of the pelvic floor diagnostic testing market. In terms of pelvic dysfunction, the pelvic floor diagnostics industry has emerged as a profitable research field. With the growing need for high-resolution pictures, the advancement of imaging technology is gaining traction. Improved knowledge and awareness of the diagnostic alternatives accessible among the expanding population is fueling demand. Ultrasound systems provide high-resolution imaging that is dependable. The pelvic floor diagnostics market is expected to see a spike in demand as the procedures for detecting, diagnosing, and treating related illnesses evolve and are less invasive. The major countries such as U.S., Canada, India, China, and Japan consistently reflect the high demand for pelvic floor diagnostics services as the countries are leading service providers for pelvic floor diagnostic services. In the pelvic floor diagnostics market, key companies such as Cooper Surgical Inc., Medtronic Plc., SRS Medical, Stryker's, MEDSPIRA, MEDKONSULT medical technology s.r.o., and EndoMed Systems are concentrating on strategic mergers and acquisitions to unlock market potential. Efficiency in new and specialized product portfolios is driving this. The market is also expected to grow as research and development efforts to detect pelvic floor diseases increase. In addition, innovations and development in product portfolio by the leading market players is likely to boost the growth of the market in the forecast timeframe. For instance, Neusoft Corporation announced their product line in June 2021, which included the NeuAngio 30F high-speed floor-mounted DSA equipment, as well as medical imaging for diagnostics.

Global Pelvic Floor Diagnostic Testing Market Segment Analysis:

The ultrasound equipment segment is dominating the Product segment of the Global Pelvic Floor Diagnostic Testing Market:

The demand for ultrasound equipment over radiographic techniques in the pelvic floor diagnostics market is growing internationally. Ultrasound systems had the largest market share of 32.6% in 2019, and are anticipated to grow at a CAGR of 5.3 % over the forecast period. There are three types of ultrasound imaging such as color doppler, power doppler, and spectral doppler. Further benefits offered by the ultrasound equipment such as no incisions, generally painless, no exposure to ionizing radiations, and accuracy in test results are projected to lift the market. A fresh interest in diagnostic imaging in urogynecology and female urology has been sparked by technological improvements in ultrasound systems. Further, growing disposable income and awareness regarding pelvic floor and learning on social media platforms are likely to drive the growth of the market in the forecast period. Global Pelvic Floor Diagnostic Testing Market The Hospital segment is considered to supplement the growth of the Global Pelvic Floor Diagnostic Testing Market. In the year 2021, the hospital's segment had the highest market share of 56.6 %, and it is expected to grow at a CAGR of 5.6% over the forecast period. By the end of the forecast period, the hospital segment is expected to generate over US$ 2,039.0 Million in revenue. Improved health infrastructure, a growing number of experienced physicians, the availability of advanced devices, and rising research and development (R&D) spending for medical devices are all contributing to the industry's growth. Further, hospital’s adopting new machineries with technological innovations and advancement are motivating the market growth.

Global Pelvic Floor Diagnostic Testing Market Regional Insights:

North America is dominating the regional market for pelvic floor diagnostic testing market. The US is leading in the Pelvic floor diagnostic market in the region which is expected to grow steadily over the forecast time frame. According to the study, the US. will have an 83.5 % market share in North America in 2021. The rising prevalence of pelvic floor disorders among pregnant women, as well as the resulting increase in healthcare expenditure, are driving the growth of the pelvic floor diagnostics market in the country. Mexico is likely to gain significant adhesion in the market accounting for 37.9% of market share in 2020. Due to the growing demand for various pelvic floor diagnostic testing services. Further, increasing investment and growing knowledge about the test and services offered by various hospitals and clinics in the regions, increasing population, and government policies are likely to boost the market expansion.Global Pelvic Floor Diagnostic Testing MarketThe objective of the report is to present a comprehensive analysis of the Global Pelvic Floor Diagnostic Testing Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Global Pelvic Floor Diagnostic Testing Market dynamics, structure by analyzing the market segments and project the Global Pelvic Floor Diagnostic Testing Market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the Global Pelvic Floor Diagnostic Testing Market make the report investor’s guide.

Global Pelvic Floor Diagnostic Testing Market Scope: Inquire before buying

Global Pelvic Floor Diagnostic Testing Market

Global Pelvic Floor Diagnostic Testing Market, by Region

• North America o US o Canada o Mexico • Europe o U.K o France o Germany o Italy o Spain o Sweden o CIS Countries o Rest of Europe • Asia Pacific o China o India o Japan o South Korea o Australia o ASEAN o Rest of Asia Pacific • The Middle East and Africa o South Africa o GCC Countries o Egypt o Nigeria o Rest of ME&A • South America o Brazil o Argentina o Rest of South America

Global Pelvic Floor Diagnostic Testing Market Key Player

Angioscore Ltd.Medtronic Inc. • St. Jude Medical • C.R.Bard • Bayer, • Endologix • Volcano Corporation • Edward Lifesciences • Endologix • Abbott Laboratories • B Braun Inc. • Cook Group Inc. • Covidien • Volcano Corporation • Cordis Corporation • Boston Scientific Corporation • Teleflex Medical • Terumo Interventional Systems Inc. • Laborie, Inc., • Cooper Surgical Inc. • SRS Medical • Stryker’ • MEDSPIRA • MEDKONSULT medical technology s.r.o. • Endo Med Systems • Richard Wolf • Schölly Fiberoptic • Zhuhai Seesheen Medical Technology • KARL STORZ • Cadwell • The Prometheus Group • Neurosoft • Noraxon USA.

FAQs:

1. What is the global Pelvic Floor Diagnostic Testing market value in 2020? Ans: Global Pelvic Floor Diagnostic Testing market value in 2020 was estimated as 3.24 Billion USD. 2. What is the global Pelvic Floor Diagnostic Testing market growth? Ans: The global Pelvic Floor Diagnostic Testing market is anticipated to grow with a CAGR of 4.3% in the forecast period and is likely to reach USD 4.35 Billion by the end of 2027. 3. Which End-User segment is expected to dominate the global Pelvic Floor Diagnostic Testing market during the forecast period? Ans: The hospital's segment had the highest market share of 56.6 %, and it is expected to grow at a CAGR of 5.6% over the forecast period. By the end of the forecast period, the hospital segment is expected to generate over US$ 2,039.0 Million in revenue. 4. Who are the key players in the Pelvic Floor Diagnostic Testing market? Ans: Some key players operating in the Pelvic Floor Diagnostic Testing market include Laborie, Inc., Cooper Surgical Inc., Medtronic Plc., SRS Medical, Stryker’s, MEDSPIRA, MEDKONSULT medical technology s.r.o., EndoMed Systems, Richard Wolf, Schölly Fiberoptic. 5. What is the key driving factor for the growth of the global Pelvic Floor Diagnostic Testing market? Ans: Key factors that are driving the Pelvic Floor Diagnostic Testing market growth include rising healthcare spending and favorable reimbursement policies that will encourage research initiatives in the market, enabling growth over the forecast period.
1.Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Pelvic Floor Diagnostic Testing Market Size, by Market Value (US$ Bn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2020 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Pelvic Floor Diagnostic Testing Market 3.4. Geographical Snapshot of the Pelvic Floor Diagnostic Testing Market, By Manufacturer share 4. Global Pelvic Floor Diagnostic Testing Market Overview, 2020-2027 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porter Five Forces Analysis 4.1.6.1. The threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. The threat of Substitute Grades 4.1.6.5. The intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Pelvic Floor Diagnostic Testing Market 5. Supply Side and Demand Side Indicators 6. Global Pelvic Floor Diagnostic Testing Market Analysis and Forecast, 2020-2027 6.1. Global Pelvic Floor Diagnostic Testing Market Size & Y-o-Y Growth Analysis. 7. Global Pelvic Floor Diagnostic Testing Market Analysis and Forecasts, 2020-2027 7.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 7.1.1. Urodynamics Systems 7.1.2. Uroflowmetry Devices 7.1.3. Anal Manometry Systems 7.1.4. Cystoscopes 7.1.5. Ultrasound Systems 7.1.5.1. Cart/Trolley Based 7.1.5.2. Portable Bladder Ultrasound Systems 7.1.6. EMG 7.2. Market Size (Value) Estimates & Forecast By End-User, 2020-2027 7.2.1. Hospital 7.2.2. Clinic 8. Global Pelvic Floor Diagnostic Testing Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2020-2027 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Pelvic Floor Diagnostic Testing Market Analysis and Forecasts, 2020-2027 9.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 9.1.1. Urodynamics Systems 9.1.2. Uroflowmetry Devices 9.1.3. Anal Manometry Systems 9.1.4. Cystoscopes 9.1.5. Ultrasound Systems 9.1.5.1. Cart/Trolley Based 9.1.5.2. Portable Bladder Ultrasound Systems 9.1.6. EMG 9.2. Market Size (Value) Estimates & Forecast By End-User, 2020-2027 9.2.1. Hospital 9.2.2. Clinic 10. North America Pelvic Floor Diagnostic Testing Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2020-2027 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Pelvic Floor Diagnostic Testing Market Analysis and Forecasts, 2020-2027 11.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 11.2. Market Size (Value) Estimates & Forecast By End-User, 2020-2027 12. Canada Pelvic Floor Diagnostic Testing Market Analysis and Forecasts, 2020-2027 12.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 12.2. Market Size (Value) Estimates & Forecast By End-User, 2020-2027 13. Mexico Pelvic Floor Diagnostic Testing Market Analysis and Forecasts, 2020-2027 13.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 13.2. Market Size (Value) Estimates & Forecast By End-User, 2020-2027 14. Europe Pelvic Floor Diagnostic Testing Market Analysis and Forecasts, 2020-2027 14.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 14.2. Market Size (Value) Estimates & Forecast By End-User, 2020-2027 15. Europe Pelvic Floor Diagnostic Testing Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2020-2027 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K Pelvic Floor Diagnostic Testing Market Analysis and Forecasts, 2020-2027 16.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 16.2. Market Size (Value) Estimates & Forecast By End-User, 2020-2027 17. France Pelvic Floor Diagnostic Testing Market Analysis and Forecasts, 2020-2027 17.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 17.2. Market Size (Value) Estimates & Forecast By End-User, 2020-2027 18. Germany Pelvic Floor Diagnostic Testing Market Analysis and Forecasts, 2020-2027 18.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 18.2. Market Size (Value) Estimates & Forecast By End-User, 2020-2027 19. Italy Pelvic Floor Diagnostic Testing Market Analysis and Forecasts, 2020-2027 19.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 19.2. Market Size (Value) Estimates & Forecast By End-User, 2020-2027 20. Spain Pelvic Floor Diagnostic Testing Market Analysis and Forecasts, 2020-2027 20.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 20.2. Market Size (Value) Estimates & Forecast By End-User, 2020-2027 21. Sweden Pelvic Floor Diagnostic Testing Market Analysis and Forecasts, 2020-2027 21.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 21.2. Market Size (Value) Estimates & Forecast By End-User, 2020-2027 22. CIS Countries Pelvic Floor Diagnostic Testing Market Analysis and Forecasts, 2020-2027 22.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 22.2. Market Size (Value) Estimates & Forecast By End-User, 2020-2027 23. Rest of Europe Pelvic Floor Diagnostic Testing Market Analysis and Forecasts, 2020-2027 23.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 23.2. Market Size (Value) Estimates & Forecast By End-User, 2020-2027 24. Asia Pacific Pelvic Floor Diagnostic Testing Market Analysis and Forecasts, 2020-2027 24.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 24.2. Market Size (Value) Estimates & Forecast By End-User, 2020-2027 25. Asia Pacific Pelvic Floor Diagnostic Testing Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2020-2027 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Pelvic Floor Diagnostic Testing Market Analysis and Forecasts, 2020-2027 26.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 26.2. Market Size (Value) Estimates & Forecast By End-User, 2020-2027 27. India Pelvic Floor Diagnostic Testing Market Analysis and Forecasts, 2020-2027 27.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 27.2. Market Size (Value) Estimates & Forecast By End-User, 2020-2027 28. Japan Pelvic Floor Diagnostic Testing Market Analysis and Forecasts, 2020-2027 28.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 28.2. Market Size (Value) Estimates & Forecast By End-User, 2020-2027 29. South Korea Pelvic Floor Diagnostic Testing Market Analysis and Forecasts, 2020-2027 29.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 29.2. Market Size (Value) Estimates & Forecast By End-User, 2020-2027 30. Australia Pelvic Floor Diagnostic Testing Market Analysis and Forecasts, 2020-2027 30.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 30.2. Market Size (Value) Estimates & Forecast By End-User, 2020-2027 31. ASEAN Pelvic Floor Diagnostic Testing Market Analysis and Forecasts, 2020-2027 31.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 31.2. Market Size (Value) Estimates & Forecast By End-User, 2020-2027 32. Rest of Asia Pacific Pelvic Floor Diagnostic Testing Market Analysis and Forecasts, 2020-2027 32.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 32.2. Market Size (Value) Estimates & Forecast By End-User, 2020-2027 33. Middle East Africa Pelvic Floor Diagnostic Testing Market Analysis and Forecasts, 2020-2027 33.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 33.2. Market Size (Value) Estimates & Forecast By End-User, 2020-2027 34. Middle East Africa Pelvic Floor Diagnostic Testing Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2020-2027 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Pelvic Floor Diagnostic Testing Market Analysis and Forecasts, 2020-2027 35.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 35.2. Market Size (Value) Estimates & Forecast By End-User, 2020-2027 36. GCC Countries Pelvic Floor Diagnostic Testing Market Analysis and Forecasts, 2020-2027 36.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 36.2. Market Size (Value) Estimates & Forecast By End-User, 2020-2027 37. Egypt Textile Reinforced Concrete e-Market Analysis and Forecasts, 2020-2027 37.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 37.2. Market Size (Value) Estimates & Forecast By End-User, 2020-2027 38. Nigeria Pelvic Floor Diagnostic Testing Market Analysis and Forecasts, 2020-2027 38.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 38.2. Market Size (Value) Estimates & Forecast By End-User, 2020-2027 39. Rest of ME&A Pelvic Floor Diagnostic Testing Market Analysis and Forecasts, 2020-2027 39.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 39.2. Market Size (Value) Estimates & Forecast By End-User, 2020-2027 40. South America Pelvic Floor Diagnostic Testing Market Analysis and Forecasts, 2020-2027 40.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 40.2. Market Size (Value) Estimates & Forecast By End-User, 2020-2027 41. South America Pelvic Floor Diagnostic Testing Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2020-2027 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Pelvic Floor Diagnostic Testing Market Analysis and Forecasts, 2020-2027 42.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 42.2. Market Size (Value) Estimates & Forecast By End-User, 2020-2027 43. Argentina Pelvic Floor Diagnostic Testing Market Analysis and Forecasts, 2020-2027 43.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 43.2. Market Size (Value) Estimates & Forecast By End-User, 2020-2027 44. Rest of South America Pelvic Floor Diagnostic Testing Market Analysis and Forecasts, 2020-2027 44.1. Market Size (Value) Estimates & Forecast By Product, 2020-2027 44.2. Market Size (Value) Estimates & Forecast By End-User, 2020-2027 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Pelvic Floor Diagnostic Testing Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Fiber Grades, and R&D Investment 45.2.2. New Grade Launches and Grade Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment, and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures, and Strategic Alliances/ Sales Agreements 45.3. Company Profile: Key Players 45.3.1. Novartis AG 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Grade Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Development 45.3.2. Angioscore Ltd. 45.3.3. Medtronic Inc. 45.3.4. St. Jude Medical 45.3.5. C.R.Bard 45.3.6. Bayer, 45.3.7. Endologix 45.3.8. Volcano Corporation 45.3.9. Edward Lifesciences 45.3.10. Endologix 45.3.11. Abbott Laboratories 45.3.12. B Braun Inc. 45.3.13. Cook Group Inc. 45.3.14. Covidien 45.3.15. Volcano Corporation 45.3.16. Cordis Corporation 45.3.17. Boston Scientific Corporation 45.3.18. Teleflex Medical 45.3.19. Terumo Interventional Systems Inc. 45.3.20. Laborie, Inc., 45.3.21. Cooper Surgical Inc. 45.3.22. SRS Medical 45.3.23. Stryker’ 45.3.24. MEDSPIRA 45.3.25. MEDKONSULT medical technology s.r.o. 45.3.26. EndoMed Systems 45.3.27. Richard Wolf 45.3.28. Schölly Fiberoptic 45.3.29. Zhuhai Seesheen Medical Technology 45.3.30. KARL STORZ 45.3.31. Cadwell 45.3.32. The Prometheus Group 45.3.33. Neurosoft 45.3.34. Noraxon USA. 46. Primary Key Insights

About This Report

Report ID 120902
Category Healthcare
Published Date Sep 2021
Updated Date
Contact Us